- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zentalis Pharmaceuticals Llc (ZNTL)
Zentalis Pharmaceuticals Llc stock price live, this page displays NASDAQ ZNTL stock exchange data. View the ZNTL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zentalis Pharmaceuticals Llc real time stock price chart below.
What Is the Zentalis Pharmaceuticals Llc Stock Price Today?
The Zentalis Pharmaceuticals Llc stock price today is 5.45.
What Is the Stock Symbol for Zentalis Pharmaceuticals Llc?
The stock ticker symbol for Zentalis Pharmaceuticals Llc is ZNTL.
Is ZNTL the Same as $ZNTL?
$ZNTL is a common way to refer to the Zentalis Pharmaceuticals Llc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Zentalis Pharmaceuticals Llc Trade On?
Zentalis Pharmaceuticals Llc is listed and trades on the NASDAQ stock exchange.
Is Zentalis Pharmaceuticals Llc a Good Stock to Buy?
Determining whether Zentalis Pharmaceuticals Llc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Zentalis Pharmaceuticals Llc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZNTL quote. (ISIN: US98943L1070)
What Is the Zentalis Pharmaceuticals Llc Stock Price Today?
The Zentalis Pharmaceuticals Llc stock price today is 5.45.
What Is the Stock Symbol for Zentalis Pharmaceuticals Llc?
The stock ticker symbol for Zentalis Pharmaceuticals Llc is ZNTL.
Is ZNTL the Same as $ZNTL?
$ZNTL is a common way to refer to the Zentalis Pharmaceuticals Llc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Zentalis Pharmaceuticals Llc Trade On?
Zentalis Pharmaceuticals Llc is listed and trades on the NASDAQ stock exchange.
Is Zentalis Pharmaceuticals Llc a Good Stock to Buy?
Determining whether Zentalis Pharmaceuticals Llc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Zentalis Pharmaceuticals Llc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZNTL quote. (ISIN: US98943L1070)
5.52
+0.32(+6.06%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.91
5.58
52 wk Range
1.13
6.95
ZNTL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.915.58
52 wk Range
1.136.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZNTL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
6.25
Upside
+13.22%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Compare ZNTL to Peers and Sector
Metrics to compare | ZNTL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZNTLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | −2.5x | −0.5x | |
PEG Ratio | −0.15 | 0.11 | 0.00 | |
Price / Book | 1.8x | 2.5x | 2.6x | |
Price / LTM Sales | - | 24.0x | 3.2x | |
Upside (Analyst Target) | 1.3% | 221.5% | 47.6% | |
Fair Value Upside | Unlock | 4.2% | 6.1% | Unlock |
Analyst Ratings
4 Buy
5 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.25
(+13.22% Upside)
Earnings
Latest Release
Mar 26, 2026
EPS / Forecast
-0.50 / -0.48
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Zentalis Pharma (ZNTL) Stock Price Today?
The Zentalis Pharma stock price today is 5.52 USD.
What Stock Exchange Does Zentalis Pharma Trade On?
Zentalis Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Zentalis Pharma?
The stock symbol for Zentalis Pharma is "ZNTL."
What Is the Zentalis Pharma Market Cap?
As of today, Zentalis Pharma market cap is 392.25M USD.
What Is Zentalis Pharma's Earnings Per Share (TTM)?
The Zentalis Pharma EPS (TTM) is -1.91.
When Is the Next Zentalis Pharma Earnings Date?
Zentalis Pharma will release its next earnings report on May 13, 2026.
From a Technical Analysis Perspective, Is ZNTL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Zentalis Pharma Stock Split?
Zentalis Pharma has split 0 times.
How Many Employees Does Zentalis Pharma Have?
Zentalis Pharma has 106 employees.
What is the current trading status of Zentalis Pharma (ZNTL)?
As of Apr 15, 2026, Zentalis Pharma (ZNTL) is trading at a price of 5.52 USD, with a previous close of 5.20 USD. The stock has fluctuated within a day range of 4.91 USD to 5.58 USD, while its 52-week range spans from 1.13 USD to 6.95 USD.
What Is Zentalis Pharma (ZNTL) Price Target According to Analysts?
The average 12-month price target for Zentalis Pharma is 6.25 USD, with a high estimate of 10 USD and a low estimate of 2 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +13.22% Upside potential.
What Is the ZNTL After Hours Price?
ZNTL's last after hours stock price is 5.10 USD, the stock has decreased by -0.10, or -1.92%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.